Burden of Illness and Treatment Assessment of Patients With Dry Eye Disease: A Cross-Sectional Survey of Real-World Patients With Dry Eye Disease in the US

Novartis

Status: Completed

Conditions: Dry Eye Disease

Study type: Observational

Funder types: Industry

Identifiers

NCT06018571

CLIF606A1US10

Details and patient eligibility

About

This study employed secondary database analysis of the Adelphi Dry Eye Disease (DED) Disease Specific Programme™ (DSP™), a templatized cross-sectional survey with retrospective data collection that is administered by Adelphi to a convenience sample of patients diagnosed with DED, and their consulting physicians in the United States. In addition to the survey data, the DED DSP also included recorded medical history data as reported by physicians (optometrists, ophthalmologists or refractive surgeons).

Enrollment: 946 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Main Sample:

• ≥ 18 years of age.
• Physician-confirmed DED diagnosis (at time of data collection).

Xiidra® Oversample:

• ≥ 18 years of age.
• Physician-confirmed DED diagnosis (at time of data collection).
• Have a current prescription for Xiidra® for their DED (at time of data collection).

Exclusion criteria

Main Sample:

• Involved in a DED clinical trial (at time of data collection).

Xiidra® Oversample:

• Involved in a DED clinical trial (at time of data collection).
• Included in the main sample previously.